NGM BIOPHARMACEUTICALS INC Depreciation
NGM BIOPHARMACEUTICALS INC reported Depreciation of $2.22 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC depreciation for the quarter ending 2023-12-31 was $518.00K, a 15.64% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC depreciation for the quarter ending 2023-09-30 was $500.00K, a 16.67% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC depreciation for the quarter ending 2023-06-30 was $600.00K, a 57.14% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC depreciation for the quarter ending 2023-03-31 was $609.00K, a 57.32% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC depreciation for fiscal 2023 was $2.22M, a 44.96% decline from fiscal 2022.
- NGM BIOPHARMACEUTICALS INC depreciation for fiscal 2022 was $4.04M, a 33.73% decline from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC depreciation for fiscal 2021 was $6.09M, a 7.11% decline from fiscal 2020.
- NGM BIOPHARMACEUTICALS INC depreciation for fiscal 2020 was $6.55M, a 13.81% decline from fiscal 2019.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.02M derived: sum of 2 quarters · filed 2024-03-11 | $1.62M derived: sum of 3 quarters · filed 2024-03-11 | $2.22M 10-K · filed 2024-03-11 |
| 2023-09-30 | $500.00K 10-Q · filed 2023-11-02 | $1.10M derived: sum of 2 quarters · filed 2023-11-02 | $1.70M 10-Q · filed 2023-11-02 | $2.32M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | $600.00K 10-Q · filed 2023-08-03 | $1.17M 10-Q · filed 2023-08-03 | $1.82M derived: sum of 3 quarters · filed 2024-03-11 | $2.42M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | $609.00K 10-Q · filed 2023-05-04 | $1.22M derived: sum of 2 quarters · filed 2024-03-11 | $1.82M derived: sum of 3 quarters · filed 2024-03-11 | $3.22M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.21M derived: sum of 2 quarters · filed 2024-03-11 | $2.61M derived: sum of 3 quarters · filed 2024-03-11 | $4.04M 10-K · filed 2024-03-11 |
| 2022-09-30 | $600.00K 10-Q · filed 2023-11-02 | $2.00M derived: sum of 2 quarters · filed 2023-11-02 | $3.42M 10-Q · filed 2023-11-02 | $4.91M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $1.40M 10-Q · filed 2023-08-03 | $2.82M 10-Q · filed 2023-08-03 | $4.31M derived: sum of 3 quarters · filed 2024-03-11 | $5.81M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $1.43M 10-Q · filed 2023-05-04 | $2.91M derived: sum of 2 quarters · filed 2024-03-11 | $4.41M derived: sum of 3 quarters · filed 2024-03-11 | $6.01M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $2.98M derived: sum of 2 quarters · filed 2024-03-11 | $4.58M derived: sum of 3 quarters · filed 2024-03-11 | $6.09M 10-K · filed 2024-03-11 |
| 2021-09-30 | $1.50M 10-Q · filed 2022-11-03 | $3.10M derived: sum of 2 quarters · filed 2022-11-03 | $4.61M 10-Q · filed 2022-11-03 | $6.21M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.60M 10-Q · filed 2022-08-04 | $3.12M 10-Q · filed 2022-08-04 | $4.71M derived: sum of 3 quarters · filed 2023-02-28 | $6.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $1.55M 10-Q · filed 2022-05-05 | $3.11M derived: sum of 2 quarters · filed 2023-02-28 | $4.71M derived: sum of 3 quarters · filed 2023-02-28 | $6.41M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.15M derived: sum of 2 quarters · filed 2023-02-28 | $4.85M derived: sum of 3 quarters · filed 2023-02-28 | $6.55M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.60M 10-Q · filed 2021-11-04 | $3.30M derived: sum of 2 quarters · filed 2021-11-04 | $5.00M 10-Q · filed 2021-11-04 | $6.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.70M 10-Q · filed 2021-08-05 | $3.38M 10-Q · filed 2021-08-05 | $5.20M derived: sum of 3 quarters · filed 2022-03-01 | $7.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.73M 10-Q · filed 2021-05-06 | $3.50M derived: sum of 2 quarters · filed 2022-03-01 | $5.40M derived: sum of 3 quarters · filed 2022-03-01 | $7.30M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.67M derived: sum of 2 quarters · filed 2022-03-01 | $5.57M derived: sum of 3 quarters · filed 2022-03-01 | $7.61M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.90M 10-Q · filed 2020-11-12 | $3.80M derived: sum of 2 quarters · filed 2020-11-12 | $5.84M 10-Q · filed 2020-11-12 | $7.65M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $1.90M 10-Q · filed 2020-08-12 | $3.90M 10-Q · filed 2020-08-12 | $5.75M derived: sum of 3 quarters · filed 2021-03-15 | $7.65M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $1.96M 10-Q · filed 2020-05-13 | $3.85M derived: sum of 2 quarters · filed 2021-03-15 | $5.75M derived: sum of 3 quarters · filed 2021-03-15 | $7.45M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.79M derived: sum of 2 quarters · filed 2021-03-15 | $5.49M derived: sum of 3 quarters · filed 2021-03-15 | $7.22M 10-K · filed 2021-03-15 |
| 2018-09-30 | $1.90M 10-Q · filed 2019-11-12 | $3.60M derived: sum of 2 quarters · filed 2019-11-12 | $5.33M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $1.70M 10-Q · filed 2019-08-12 | $3.45M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $1.74M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | $6.44M 10-K · filed 2020-03-17 |